<?xml version="1.0" encoding="UTF-8"?>
<ref id="R84">
 <label>84</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Ascierto</surname>
    <given-names>PA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Fox</surname>
    <given-names>BA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Urba</surname>
    <given-names>WJ</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Insights from immuno-oncology: the Society for immunotherapy of cancer statement on access to IL-6-targeting therapies for COVID-19</article-title>. 
  <source>J Immunother Cancer</source>
  <year>2020</year>;
  <volume>8</volume>:
  <elocation-id>e000878</elocation-id>. 
  <pub-id pub-id-type="doi">10.1136/jitc-2020-000878</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/32300051?>
  <pub-id pub-id-type="pmid">32300051</pub-id>
 </mixed-citation>
</ref>
